LND101 for Fecal Microbiota Transplantation in Combination With Immune Checkpoint Blockade in Advanced Melanoma | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
LND101 for Fecal Microbiota Transplantation in Combination With Immune Checkpoint Blockade in Advanced Melanoma	Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasm	Recruiting	Phase 2	2026-09-15		NCT06623461

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Canadian Cancer Society (CCS)	26
Canadian Cancer Trials Group	73
Canadian Institutes of Health Research (CIHR)	339
Weston Family Foundation	5

15 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
BCCA - Abbotsford	Abbotsford British Columbia	Canada	1
BCCA - Surrey	Surrey	Canada	2
BCCA - Vancouver	Vancouver	Canada	22
Centre hospitalier regional de Trois-Rivieres	Trois-Rivières	Canada	4
Centre Integre de Sante et de Services Sociaux	Greenfield Park	Canada	2
CHUM-Centre Hospitalier de l'Universite de Montreal	Montreal	Canada	20
Hotel-Dieu de Quebec	Québec	Canada	10
Juravinski Cancer Centre at Hamilton Health Sciences	Hamilton	Canada	60
London Health Sciences Centre Research Inc.	London	Canada	13
Odette Cancer Centre	Toronto	Canada	20
Ottawa Hospital Research Institute	Ottawa	Canada	46
Stronach Regional Health Centre at Southlake	Newmarket	Canada	14
The Jewish General Hospital	Montreal	Canada	20
The Research Institute of the McGill University	Montreal	Canada	10
University Health Network	Toronto	Canada	52